JFG
LXRX icon

Jefferies Financial Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jefferies Financial Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-68,734
Closed -$107K – 1885
2026
Q1 		$107K Sell
68,734
-23,796
-26% -$34.6K ﹤0.01% 1590
2025
Q4 		$106K Sell
92,530
-4,870
-5% -$6.69K ﹤0.01% 1696
2025
Q3 		$131K Buy
+97,400
New +$111K ﹤0.01% 1319

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jefferies Financial Group's LXRX Position: Q2 2026 in Review

Jefferies Financial Group sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 68,734 shares — an estimated $107K sold.

Jefferies Financial Group first reported a position in LXRX in Q3 2025 and held it in 3 quarters. The position peaked at $131K in Q3 2025. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Jefferies Financial Group reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 68,734 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $107K.
  • Jefferies Financial Group first reported a position in Lexicon Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Jefferies Financial Group's Lexicon Pharmaceuticals position peaked at $131K in Q3 2025.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.